Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.

ABSTRACT: Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31-December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.

SUBMITTER: Doi A 

PROVIDER: S-EPMC11138985 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature